LUNG logo

Pulmonx (LUNG) Company Overview

Profile

Full Name:

Pulmonx Corporation

Sector:

Healthcare

Country:

United States

IPO:

October 1, 2020

Indexes:

Not included

Description:

LUNG (Pulmonx) is a medical company that focuses on innovative treatments for lung diseases. They develop advanced technologies to help patients with conditions like emphysema. Their main product, the Zephyr Valve, improves breathing by reducing lung volume and enhancing airflow, leading to better quality of life for patients.

Key Details

Price

$8.77

Annual Revenue

$83.79 M(+22.01% YoY)

Annual EPS

-$1.44(+10.00% YoY)

Annual ROE

-55.25%

Beta

1.16

Events Calendar

Earnings

Next earnings date:

May 1, 2025

Recent quarterly earnings:

Feb 19, 2025

Recent annual earnings:

Feb 19, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 11, 24 Wells Fargo
Equal-Weight
Dec 11, 24 Citigroup
Neutral
Oct 31, 24 Stifel
Buy
Aug 1, 24 Wells Fargo
Equal-Weight
Aug 1, 24 Piper Sandler
Overweight
Aug 1, 24 Canaccord Genuity
Buy
Jun 4, 24 Lake Street
Buy
May 2, 24 Canaccord Genuity
Buy
Apr 3, 24 Piper Sandler
Overweight
Feb 23, 24 Wells Fargo
Equal-Weight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Pulmonx?
  • Does Pulmonx pay dividends?
  • What sector is Pulmonx in?
  • What industry is Pulmonx in?
  • What country is Pulmonx based in?
  • When did Pulmonx go public?
  • Is Pulmonx in the S&P 500?
  • Is Pulmonx in the NASDAQ 100?
  • Is Pulmonx in the Dow Jones?
  • When was Pulmonx's last earnings report?
  • When does Pulmonx report earnings?
  • Should I buy Pulmonx stock now?

What is the ticker symbol for Pulmonx?

The ticker symbol for Pulmonx is NASDAQ:LUNG

Does Pulmonx pay dividends?

No, Pulmonx does not pay dividends

What sector is Pulmonx in?

Pulmonx is in the Healthcare sector

What industry is Pulmonx in?

Pulmonx is in the Medical Devices industry

What country is Pulmonx based in?

Pulmonx is headquartered in United States

When did Pulmonx go public?

Pulmonx's initial public offering (IPO) was on October 1, 2020

Is Pulmonx in the S&P 500?

No, Pulmonx is not included in the S&P 500 index

Is Pulmonx in the NASDAQ 100?

No, Pulmonx is not included in the NASDAQ 100 index

Is Pulmonx in the Dow Jones?

No, Pulmonx is not included in the Dow Jones index

When was Pulmonx's last earnings report?

Pulmonx's most recent earnings report was on Feb 19, 2025

When does Pulmonx report earnings?

The next expected earnings date for Pulmonx is May 1, 2025

Should I buy Pulmonx stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions